Amarin Corporation
AMRN
$0.91
Share price
-0.87%
Change (1 day)
-33.58%
Change (1 year)
Categories
P/S ratio for Amarin Corporation (AMRN)
P/S ratio as of May 2024 (TTM): 1.20
According to Amarin Corporation 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.20049. At the end of 2023 the company had a P/S ratio of 1.16.
P/S ratio history for Amarin Corporation from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.16 | -12.55% |
| 2022 | 1.32 | -42.14% |
| 2021 | 2.29 | -26.83% |
| 2020 | 3.13 | -82.6% |
| 2019 | 18.0 | -7.15% |
| 2018 | 19.3 | 222.58% |
| 2017 | 6.00 | -6.16% |
| 2016 | 6.39 | 50.75% |
| 2015 | 4.24 | 34.35% |
| 2014 | 3.16 | -75.55% |
| 2013 | 12.9 | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2006 | 206 | 123.69% |
| 2005 | 92.2 | |
| 2004 | N/A | |
| 2003 | N/A | -100% |
| 2002 | 0.5992 | -97.58% |
| 2001 | 24.8 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 AbbVie ABBV | 5.24 | 336.66% | 🇺🇸 USA |
 AstraZeneca AZN | 4.94 | 311.18% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 2.34 | 94.53% | 🇬🇧 UK |
 Alkermes ALKS | 2.43 | 102.15% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | 1.01 | -16.17% | 🇮🇱 Israel |